Industry faces talent crunch and regulatory strain, according to third Global Biopharma Index from Cytiva
Cytiva, a Danaher company and a leader in the life sciences industry, has launched its third Global Biopharma Index. Every two years, Cytiva surveys 1250 biopharma executives across 22 countries and asks them to rate, on a scale of 0 to 10, the biopharma ecosystem across six pillars: supply chain resilience, talent po…
